Novartis' New Cancer Drug Shows Early Success in Fighting Prostate Cancer

A new experimental drug from Novartis is making waves in the fight against prostate cancer. Early trial results show it shrinks tumors in patients, even those who stopped responding to the company's existing treatment, Pluvicto. The drug uses a different radioactive element called actinium-225, whic